Alexion Pharmaceuticals, Inc.

Alexion Pharmaceuticals, Inc. is engaged in the research, development, and delivery of therapies and medicines for rare diseases. The company develops and delivers therapies for rare diseases and conditions, and provides patient support programs that include disease and treatment education, assistance with navigating health insurance coverage, and help with starting prescribed treatments. It offers resources to connect patients with the rare disease community and support services, which may include diagnosis support, transportation assistance, or multidisciplinary services depending on the country. The company conducts research and development activities, including clinical trials, and uses diagnostics and artificial intelligence systems in its R&D processes. It engages with advocacy groups, research teams, and stakeholders to improve access to care and health outcomes. The company serves patients living with rare diseases, caregivers, advocacy groups, research teams, and stakeholders in the healthcare and life sciences sectors. The company was founded in 1992 and is based in Boston, Massachusetts.